Pursuant to SEBI Circular No. SEBI/HO/CFD/CFD-PoD-2/CIR/P/2024/185 dated December 31, 2024, read with BSE Circular No. 20250102-4 and NSE Circular No. NSE/CML/2025/02 dated January 2, 2025, Divi's Laboratories has submitted the Integrated Filing (Financial) for the quarter and nine months ended December 31, 2024. The above information is also available on the website of the Company at https://www.divislabs.com/investor-relations/statutory-communication/.
The above information is a part of company’s filings submitted to BSE.